Skip to main content
Erschienen in: Rheumatology International 7/2016

09.04.2016 | Epidemiology of RMD

Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran

verfasst von: Hadi Poormoghim, Elham Andalib, Arash Jalali, Afshin Ghaderi, Ali Ghorbannia, Nazanin Mojtabavi

Erschienen in: Rheumatology International | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

The aims of the study were to determine prognostic factors for survival and causes of death in a cohort of patients with systemic sclerosis (SSc). This was a cohort study of SSc patients in single rheumatologic center from January 1998 to August 2012. They fulfilled the American College of Rheumatology classification criteria for SSc or had calcinosis Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia or sine sclerosis. Causes of death were classified as SSc related and non-SSc related. Kaplan–Meier and Cox proportional hazard regression models were used in univariate and multivariate analysis to analyse survival in subgroups and determine prognostic factors of survival. The study includes 220 patients (192 female, 28 male). Out of thirty-two (14.5 %) who died, seventeen (53.1 %) deaths were SSc related and in nine (28.1 %) non-SSc-related causes, and in six (18.8 %) of patients causes of death were not defined. Overall survival rate was 92.6 % (95 % CI 87.5–95.7 %) after 5 years and 82.3 % (95 % CI 73.4–88.4 %) after 10 years. Pulmonary involvement was a major SSc-related cause of death, occurred in seven (41.1 %) patients. Cardiovascular events were leading cause of in overall death (11) 34.3 % and 6 in non-SSc-related death. Independent risk factors for mortality were age >50 at diagnosis (HR 5.10) advance pulmonary fibrosis (HR 11.5), tendon friction rub at entry (HR 6.39), arthritis (HR 3.56). In this first Middle Eastern series of SSc registry, pulmonary and cardiac involvements were the leading cause of SSc-related death.
Literatur
1.
Zurück zum Zitat Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H (1971) Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 75:369–376CrossRefPubMed Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H (1971) Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 75:369–376CrossRefPubMed
2.
Zurück zum Zitat Perez-Bocanegra C, Solans-Laque R, Simeon-Aznar CP et al (2010) Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology 49:1112–1117CrossRefPubMed Perez-Bocanegra C, Solans-Laque R, Simeon-Aznar CP et al (2010) Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology 49:1112–1117CrossRefPubMed
3.
Zurück zum Zitat Fransen J, Popa-Diaconu D, Hesselstrand R et al (2011) Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis 70:1788–1792CrossRefPubMed Fransen J, Popa-Diaconu D, Hesselstrand R et al (2011) Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis 70:1788–1792CrossRefPubMed
4.
Zurück zum Zitat Hesselstrand R, Scheja A, Akesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57:682–686CrossRefPubMedPubMedCentral Hesselstrand R, Scheja A, Akesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57:682–686CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:10CrossRef Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:10CrossRef
6.
Zurück zum Zitat Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 81:139–153CrossRefPubMed Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 81:139–153CrossRefPubMed
7.
Zurück zum Zitat Lee P, Langevitz P, Alderdice CA et al (1992) Mortality in systemic sclerosis (scleroderma). Q J Med 82:139–148PubMed Lee P, Langevitz P, Alderdice CA et al (1992) Mortality in systemic sclerosis (scleroderma). Q J Med 82:139–148PubMed
8.
Zurück zum Zitat Czirják L, Kumánovics G, Varjú C et al (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67:59–63CrossRefPubMed Czirják L, Kumánovics G, Varjú C et al (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67:59–63CrossRefPubMed
9.
Zurück zum Zitat Kim J, Park SK, Moon KW, Lee EY, Lee YJ, Song YW et al (2010) The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol 29:297–302CrossRefPubMed Kim J, Park SK, Moon KW, Lee EY, Lee YJ, Song YW et al (2010) The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol 29:297–302CrossRefPubMed
10.
Zurück zum Zitat Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M et al (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42:71–75CrossRefPubMed Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M et al (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42:71–75CrossRefPubMed
11.
Zurück zum Zitat Al-Dhaher FF, Pope JE, Ouimet JM (2010) Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 39:269–277CrossRefPubMed Al-Dhaher FF, Pope JE, Ouimet JM (2010) Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 39:269–277CrossRefPubMed
12.
Zurück zum Zitat Steen VD, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44:2828–2835CrossRefPubMed Steen VD, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44:2828–2835CrossRefPubMed
13.
Zurück zum Zitat Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 81:154–167CrossRefPubMed Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 81:154–167CrossRefPubMed
14.
Zurück zum Zitat Ruangjutipotan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis. J Med Assoc Thai 85:1204–1209 Ruangjutipotan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis. J Med Assoc Thai 85:1204–1209
15.
Zurück zum Zitat Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459PubMed Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459PubMed
16.
Zurück zum Zitat Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10CrossRefPubMed Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10CrossRefPubMed
17.
Zurück zum Zitat Arias-Nuñez MC, Llorca J, Vazquez-Rodrigues TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J et al (2008) Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine 87:272–280CrossRefPubMed Arias-Nuñez MC, Llorca J, Vazquez-Rodrigues TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J et al (2008) Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine 87:272–280CrossRefPubMed
18.
Zurück zum Zitat Martini G, Vittadello F, Kasapçopur O, Magni Manzoni S, Corona F, Duarte-Salazar C et al (2009) Factors affecting survival in juvenile systemic sclerosis. Rheumatology 48:119–122CrossRefPubMed Martini G, Vittadello F, Kasapçopur O, Magni Manzoni S, Corona F, Duarte-Salazar C et al (2009) Factors affecting survival in juvenile systemic sclerosis. Rheumatology 48:119–122CrossRefPubMed
19.
Zurück zum Zitat Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246–2255CrossRefPubMed Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246–2255CrossRefPubMed
20.
Zurück zum Zitat Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B et al (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis. Arthritis Rheum 43:2445–2454CrossRefPubMed Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B et al (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis. Arthritis Rheum 43:2445–2454CrossRefPubMed
21.
Zurück zum Zitat Altman RD, Medsger TA Jr, Bloch DA, Michel BA (1991) Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403–413CrossRefPubMed Altman RD, Medsger TA Jr, Bloch DA, Michel BA (1991) Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403–413CrossRefPubMed
22.
Zurück zum Zitat Nagy Z, Czirják L (2005) Increased C reactive protein and aminoterminal propeptide of type III procollagen levels are unfavourable predictors of survival in systemic sclerosis (scleroderma). Clin Exp Rheumatol 23:165–172PubMed Nagy Z, Czirják L (2005) Increased C reactive protein and aminoterminal propeptide of type III procollagen levels are unfavourable predictors of survival in systemic sclerosis (scleroderma). Clin Exp Rheumatol 23:165–172PubMed
23.
Zurück zum Zitat Bulpitt KJ, Clements PL, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS et al (1993) Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 118:602–609CrossRefPubMed Bulpitt KJ, Clements PL, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS et al (1993) Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 118:602–609CrossRefPubMed
24.
Zurück zum Zitat Bryan C, Knight C, Black CM, Silman AJ (1999) Prediction of five-year survival following presentation with scleroderma development of a simple model using three disease factors at first visit. Arthritis Rheum 42:2660–2665CrossRefPubMed Bryan C, Knight C, Black CM, Silman AJ (1999) Prediction of five-year survival following presentation with scleroderma development of a simple model using three disease factors at first visit. Arthritis Rheum 42:2660–2665CrossRefPubMed
25.
Zurück zum Zitat Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol 84:359–371CrossRefPubMed Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol 84:359–371CrossRefPubMed
26.
Zurück zum Zitat Joven BE, Almodovar R, Carmona L, Carreira PE (2010) Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum 39:285–293CrossRefPubMed Joven BE, Almodovar R, Carmona L, Carreira PE (2010) Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum 39:285–293CrossRefPubMed
27.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
28.
Zurück zum Zitat Bennett RM (1990) Scleroderma overlaps syndromes. Rheum Dis Clin North Am 16:185–198PubMed Bennett RM (1990) Scleroderma overlaps syndromes. Rheum Dis Clin North Am 16:185–198PubMed
29.
Zurück zum Zitat Poormoghim H, Lucas M, Fertig N, Medsger TA Jr (2000) Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 43:444–451CrossRefPubMed Poormoghim H, Lucas M, Fertig N, Medsger TA Jr (2000) Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 43:444–451CrossRefPubMed
30.
Zurück zum Zitat LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
31.
Zurück zum Zitat Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590CrossRef Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590CrossRef
33.
Zurück zum Zitat Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208–219CrossRefPubMed Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208–219CrossRefPubMed
34.
Zurück zum Zitat Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a studyfrom the EULAR Scleroderma Trials and Research (EUSTAR). Ann Rheum Dis 69:1809–1815CrossRefPubMed Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a studyfrom the EULAR Scleroderma Trials and Research (EUSTAR). Ann Rheum Dis 69:1809–1815CrossRefPubMed
35.
Zurück zum Zitat Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755CrossRefPubMed Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755CrossRefPubMed
36.
Zurück zum Zitat Bryan C, Howard Y, Brennan P, Black C, Silman A (1996) Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 35:1122–1126CrossRefPubMed Bryan C, Howard Y, Brennan P, Black C, Silman A (1996) Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 35:1122–1126CrossRefPubMed
37.
Zurück zum Zitat Belch JJ, McSwiggan S, Lau C (2008) Macrovascular disease in systemic sclerosis: the tip of an iceberg? Rheumatology 47(Suppl 5):v16–v17CrossRefPubMed Belch JJ, McSwiggan S, Lau C (2008) Macrovascular disease in systemic sclerosis: the tip of an iceberg? Rheumatology 47(Suppl 5):v16–v17CrossRefPubMed
38.
Zurück zum Zitat Hashimoto A, Tejima S, Tono T et al (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38:1931–1939CrossRefPubMed Hashimoto A, Tejima S, Tono T et al (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38:1931–1939CrossRefPubMed
39.
Zurück zum Zitat Walker UA, Tyndall A, Czirják L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66:754–763CrossRefPubMedPubMedCentral Walker UA, Tyndall A, Czirják L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66:754–763CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101:59–62CrossRefPubMed Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101:59–62CrossRefPubMed
41.
Zurück zum Zitat Olesen AB, Svaerke C, Farkas DK, Sørensen HT (2010) Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 163:800–806CrossRefPubMed Olesen AB, Svaerke C, Farkas DK, Sørensen HT (2010) Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 163:800–806CrossRefPubMed
42.
Zurück zum Zitat Doré A, Lucas M, Dana Ivanco D, Medsger TA, Domsic R (2013) The significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis. Arthritis Care Res 65:1385–1389CrossRef Doré A, Lucas M, Dana Ivanco D, Medsger TA, Domsic R (2013) The significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis. Arthritis Care Res 65:1385–1389CrossRef
43.
Zurück zum Zitat Avouac J, Clements PJ, Khanna D et al (2012) Articular involvement in systemic sclerosis. Rheumatology 51:1347–1356CrossRefPubMed Avouac J, Clements PJ, Khanna D et al (2012) Articular involvement in systemic sclerosis. Rheumatology 51:1347–1356CrossRefPubMed
44.
Zurück zum Zitat Poormoghim H, Moghadam AS, Moradi-Lakeh M et al (2013) Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients. Rheumatol Int 33:1943–1950CrossRefPubMed Poormoghim H, Moghadam AS, Moradi-Lakeh M et al (2013) Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients. Rheumatol Int 33:1943–1950CrossRefPubMed
45.
Zurück zum Zitat Sujau I, Ng CT, Sthaneshwar P et al (2015) Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort. Int J Rheum Dis 18:459–465CrossRefPubMed Sujau I, Ng CT, Sthaneshwar P et al (2015) Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort. Int J Rheum Dis 18:459–465CrossRefPubMed
46.
Zurück zum Zitat Wang J, Assassi S, Guo G et al (2013) Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol 32:617–621CrossRefPubMed Wang J, Assassi S, Guo G et al (2013) Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol 32:617–621CrossRefPubMed
47.
Zurück zum Zitat Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444CrossRefPubMed Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444CrossRefPubMed
48.
Zurück zum Zitat Kahan A, Nitenberg A, Foult JM et al (1985) Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 28:637–646CrossRefPubMed Kahan A, Nitenberg A, Foult JM et al (1985) Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 28:637–646CrossRefPubMed
Metadaten
Titel
Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran
verfasst von
Hadi Poormoghim
Elham Andalib
Arash Jalali
Afshin Ghaderi
Ali Ghorbannia
Nazanin Mojtabavi
Publikationsdatum
09.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 7/2016
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3475-6

Weitere Artikel der Ausgabe 7/2016

Rheumatology International 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.